Indinavir

Chemical formula: C₃₆H₄₇N₅O₄  Molecular mass: 613.79 g/mol  PubChem compound: 5362440

Therapeutic indications

Indinavir is indicated for:

HIV-1 infection

Population group: only adults (18 - 65 years old)

Indinavir is indicated in combination with antiretroviral nucleoside analogues for the treatment of HIV-1 infected adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

HIV-1 infection

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Indinavir is indicated in combination with antiretroviral nucleoside analogues for the treatment of HIV-1 infected adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Indinavir is contraindicated in the following cases:

Rifampicin

Rifampicin

Ritonavir, quinidine

Ritonavir and additionally Quinidine

Quetiapine

Quetiapine

St. John’s wort (Hypericum perforatum)

Hypericum perforatum (St John's Wort)

Lovastatin, simvastatin

at least one of
Lovastatin
Simvastatin

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2018: CRIXIVAN Hard capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈